According to the identified key genes predominantly involved in the PI3K/AKT signaling pathway and the results of KEGG analysis, it can be inferred that the PI3K/AKT signaling pathway plays a pivotal role in BYD’s mechanisms of action for asthma treatment. This evidence concerns the gene AKT1 and asthma.